Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
PURPOSE: To determine the activity and toxicity of combined 24-hour infusion of paclitaxel with carboplatin in advanced non-small cell lung cancer. PATIENTS AND METHODS: Eligibility required measurable disease; stage III B with malignant pleural effusion or stage IV disease, with a performance statu...
Saved in:
Main Authors: | Chaiyut Charoentum, Sumitra Thongprasert, Busayamas Chewasakulyong |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=38449083083&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60883 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
by: Charoentum C., et al.
Published: (2014) -
A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018) -
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018) -
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Chaiyut Charoentum, et al.
Published: (2018) -
The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
by: Primandono Perbowo, -, et al.
Published: (2019)